Stuart Woods

发表

CSGID Solves Structures and Identifies Phenotypes for Five Enzymes in Toxoplasma gondii

C. Fishwick, D. Roos, Dhanasekaran Shanmugam, 2018, Front. Cell. Infect. Microbiol..

Limited Impact of the Protein Corona on the Cellular Uptake of PEGylated Zein Micelles by Melanoma Cancer Cells

C. Roberts, C. Dufès, Sukrut Somani, 2022, Pharmaceutics.

The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency

C. Roberts, Giulia Anderluzzi, Gustavo Lou, 2021, Journal of Controlled Release.

Rational design of adjuvants for subunit vaccines: The format of cationic adjuvants affects the induction of antigen-specific antibody responses.

C. Roberts, I. Ferlenghi, D. Veggi, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomes.

C. Roberts, U. D'Oro, R. Adamo, 2020, Journal of controlled release : official journal of the Controlled Release Society.

A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: formulation, cellular uptake and biodistribution investigations.

C. Roberts, Giulia Anderluzzi, Gustavo Lou, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

MAP Kinase Phosphatase-2 Plays a Key Role in the Control of Infection with Toxoplasma gondii by Modulating iNOS and Arginase-1 Activities in Mice

C. Roberts, R. Plevin, Stuart Woods, 2013, PLoS pathogens.

Novel protective role for MAP kinase phosphatase 2 in inflammatory arthritis

R. Plevin, J. Crowe, C. Lawrence, 2019, RMD Open.

1 Acanthamoeba activates macrophages predominantly through TLR 4 and MyD 881 dependent mechanisms to induce IL-12 and IL-6 2 3 4

Alexander, C. Roberts, Stuart Woods, 2018 .

Acanthamoeba Activates Macrophages Predominantly through Toll-Like Receptor 4- and MyD88-Dependent Mechanisms To Induce Interleukin-12 (IL-12) and IL-6

C. Roberts, Stuart Woods, A. Mattana, 2017, Infection and Immunity.

T Cell Hypo-Responsiveness against Leishmania major in MAP Kinase Phosphatase (MKP) 2 Deficient C57BL/6 Mice Does Not Alter the Healer Disease Phenotype

R. Plevin, Stuart Woods, J. Alexander, 2013, PLoS neglected tropical diseases.

Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection.

C. Roberts, I. Ferlenghi, Giulia Anderluzzi, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Salicylanilide inhibitors of Toxoplasma gondii.

C. Roberts, R. McLeod, W. Welsh, 2012, Journal of medicinal chemistry.

Immunogenetics of Toxoplasma gondii informs vaccine design.

C. Roberts, R. McLeod, Stuart Woods, 2010, Trends in parasitology.

The effect of murine gene deficiencies on the outcome of Toxoplasma gondii infection

C. Roberts, Stuart Woods, 2020 .

Multi-Omics Studies Demonstrate Toxoplasma gondii-Induced Metabolic Reprogramming of Murine Dendritic Cells

C. Roberts, Stuart Woods, G. Westrop, 2019, Front. Cell. Infect. Microbiol..

Glucosamine-NISV delivers antibody across the blood-brain barrier: Optimization for treatment of encephalitic viruses.

C. Roberts, J. Preston, Stuart Woods, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Exploitation of the bilosome platform technology to formulate antibiotics and enhance efficacy of melioidosis treatments

C. Roberts, Y. Perrie, Stuart Woods, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Modification of Triclosan Scaffold in Search of Improved Inhibitors for Enoyl‐Acyl Carrier Protein (ACP) Reductase in Toxoplasma gondii

D. Rice, S. Prigge, C. Roberts, 2013, ChemMedChem.

Parasites lacking the micronemal protein MIC2 are deficient in surface attachment and host cell egress, but remain virulent in vivo

C. Roberts, G. Pall, J. M. Leung, 2017, Wellcome open research.

Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii.

J. Sidney, A. Sette, K. El Bissati, 2016, JCI insight.

New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections

L. Hood, C. Fishwick, J. Dubey, 2016, Scientific Reports.

Frog nest foams exhibit pharmaceutical foam-like properties

P. Hoskisson, D. Lamprou, Stuart Woods, 2021, bioRxiv.

Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice.

J. Sidney, A. Sette, W. Witola, 2012, Human immunology.

Author Correction: New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections

L. Hood, C. Fishwick, J. Dubey, 2020, Scientific Reports.

Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites

C. Fishwick, K. El Bissati, C. Roberts, 2020, Frontiers in Cellular and Infection Microbiology.

Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase.

D. Rice, S. Prigge, C. Roberts, 2013, Bioorganic & medicinal chemistry letters.

The benzimidazole based drugs show good activity against T. gondii but poor activity against its proposed enoyl reductase enzyme target.

D. Rice, C. Fishwick, S. Prigge, 2014, Bioorganic & medicinal chemistry letters.

An Exaggerated Immune Response in Female BALB/c Mice Controls Initial Toxoplasma gondii Multiplication but Increases Mortality and Morbidity Relative to Male Mice

C. Roberts, Stuart Woods, Rasha Alonaizan, 2021, Pathogens.

Immunogenetics of Toxoplasma gondii informs vaccine design.

C. Roberts, R. McLeod, Stuart Woods, 2010, Trends in Parasitology.

Modification of Triclosan Scaffold in Search of Improved Inhibitors for Enoyl‐Acyl Carrier Protein (ACP) Reductase in Toxoplasma gondii

D. Rice, S. Prigge, C. Roberts, 2013, ChemMedChem.